Article Versions Notes

Papadakos SP, Ferraro D, Carbone G, Frampton AE, Vennarecci G, Kykalos S, Schizas D, Theocharis S, Machairas N. The Emerging Role of Metformin in the Treatment of Hepatocellular Carcinoma: Is There Any Value in Repurposing Metformin for HCC Immunotherapy? Cancers. 2023; 15(12):3161. https://doi.org/10.3390/cancers15123161

Papadakos, Stavros P., Daniele Ferraro, Gabriele Carbone, Adam Enver Frampton, Giovanni Vennarecci, Stylianos Kykalos, Dimitrios Schizas, Stamatios Theocharis, and Nikolaos Machairas. 2023. "The Emerging Role of Metformin in the Treatment of Hepatocellular Carcinoma: Is There Any Value in Repurposing Metformin for HCC Immunotherapy?" Cancers 15, no. 12: 3161. https://doi.org/10.3390/cancers15123161

Papadakos, S. P., Ferraro, D., Carbone, G., Frampton, A. E., Vennarecci, G., Kykalos, S., Schizas, D., Theocharis, S., & Machairas, N. (2023). The Emerging Role of Metformin in the Treatment of Hepatocellular Carcinoma: Is There Any Value in Repurposing Metformin for HCC Immunotherapy? Cancers, 15(12), 3161. https://doi.org/10.3390/cancers15123161